Telmisartan

530 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

530

Total Reports

Deaths Reported

720.0%

Death Rate

Active Ingredients

Telmisartan

Administration Routes

OralUnknownSubcutaneousTopical

Species Affected

Cat 289

Dog 167

Unknown 72

Human 2

Most Affected Breeds

Domestic Shorthair 170

Unknown 74

Cat (other) 25

Cat (unknown) 24

Domestic Longhair 20

Terrier - Yorkshire 16

Retriever - Labrador 16

Retriever - Golden 11

Domestic Mediumhair 10

Terrier (unspecified) 10

Most Reported Reactions

Lack of efficacy - NOS 113

Vomiting 106

Diarrhoea 55

Weight loss 44

Elevated creatinine 44

Decreased appetite 36

Lethargy (see also Central nervous system depression in Neurological) 34

Elevated blood urea nitrogen (BUN) 30

Lethargy (see also Central nervous system depression in 'Neurological') 27

Anaemia NOS 27

Appearance, Abnormal 27

Death by euthanasia 25

Outcome Breakdown

Outcome Unknown

253 (55.2%)

Recovered/Normal

89 (19.4%)

Ongoing

78 (17.0%)

Euthanized

27 (5.9%)

Died

11 (2.4%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.